IP Library Assignment 066375/0189
Patent Assignment
Reel/Frame 066375/0189

Assignment of Assignor's Interest

Recorded: 2024-01-26 Pages: 27
Assignor
ESBATECH, A NOVARTIS COMPANY LLC
Executed: 2019-05-08
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Sequence Based Engineering and Optimization of Single Chain Antibodies
Patent: 8,280,711 →
Application: 12/530,756 →
Publication: US 2010/0137150
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 8, 2009
From: URECH, DAVID M; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 023345/0456 →
Change of Name Dec 11, 2009
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT GMBH
Reel/Frame 023639/0314 →
Corrective Assignment to Correct the Legal Status of the Assignee as Llc, Not Gmbh Previously Recorded on Reel 023639 Frame 0314. Assignor(S) Hereby Confirms the Legal Status of the Assignee Is Esbatech, an Alcon Biomedical Research Unit Llc. Jan 4, 2010
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 023720/0976 →
Assignment of Assignor's Interest Dec 13, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 047768/0136 →